![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Impulse Dynamics’ Heart Failure Device
FDA Approves Impulse Dynamics’ Heart Failure Device
![Grey Approved Stamp](https://www.fdanews.com/ext/resources/test/Drug-Images4/Grey_Approved_Stamp.gif?t=1576541258&width=430)
March 25, 2019
The FDA approved Impulse Dynamics’ implantable Optimizer Smart System for treating heart failure.
The breakthrough device, which received a 12-0 vote from the FDA’s Medical Devices Advisory Committee in December 2018, is intended for patients who have mildly to moderately reduced left ventricular ejection fractions and aren’t eligible for cardiac resynchronization therapy.
The device delivers an electrical pulse just after the heart contracts to modulate the strength of the heart muscle contraction rather than the rhythm.
Upcoming Events
-
21Oct